title: Marked reduction of tardive dyskinesia with olanzapine.
authors.forename: K H
authors.initials: KH
authors.lastname: Littrell
authors.forename: C G
authors.initials: CG
authors.lastname: Johnson
authors.forename: S
authors.initials: S
authors.lastname: Littrell
authors.forename: C D
authors.initials: CD
authors.lastname: Peabody
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines; D004409:Dyskinesia, Drug-Induced / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D000077152:Olanzapine; D010808:Physical Examination; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine